Latest Breaking News On - கட்டாய உரிமம் - Page 1 : comparemela.com
Authors: Olga Gurgula and John Hull
Abstract: This paper considers how vaccine technology to meet the challenges of the COVID-19 pandemic can be made available to increase the production of the vaccines. Its primary focus is on trade secrets which are one of the main intellectual property rights protecting the complex manufacturing processes for vaccine production. The compulsory licensing of trade secrets presents some unique obstacles and consideration is given to some practical solutions which might balance the interests of technology owners and the public interest in increased access to vaccines. In particular, this paper suggests that to make the currently discussed proposals on accelerating the production of COVID-19 vaccines, including compulsory licensing of patents and the IP waiver, work an additional mechanism of compulsory licensing of trade secrets is required. It is believed that the proposal for a new mechanism of compulsory licencing of trade secrets coupled with the
John-hull
Olga-gurgula
Involuntary-technology-transfer
Queen-mary-law-research-paper-no
Compulsory-licensing
Trade-secrets
Ensuring-access
Queen-mary-law-research-paper
ஜான்-ஹல்
கட்டாய-உரிமம்
வர்த்தகம்-ரகசியங்கள்
Anshika Gubrele and Subodh Asthana, both students at Bharati Vidyapeeth (Deemed to be University) New Law College, Pune and Hidayatullah National Law University, Raipur, in India, respectively, discuss the proposed patent waiver for manufacturing COVID-19 vaccines and its legal implications.
While the entire world is in the grips of the ongoing COVID-19 pandemic, 62 co-sponsor countries including India, South Africa, and Indonesia have recently given a revised draft proposal for waiving the Intellectual Property (“IP”) rights of COVID vaccines to the TRIPS Council of the World Trade Organisation (“WTO”), seeking a patent waiver for manufacturing various COVID-19 medical props including vaccines.
Japan
United-states
India
United-kingdom
Raipur
Chhattisgarh
Pune
Maharashtra
Brazil
South-africa
Indonesia
America
Highlights
Dr Paul said the Centre is doing all the heavy-lifting, from funding vaccine manufacturers to giving them quick approvals to ramping up production The vaccine procured by the Centre is supplied wholly to the states for free administration to people. All this is very much in the knowledge of the states, he added
New Delhi: Amid the ongoing COVID-19 vaccination programme across the country, the government has addressed seven myths arising due to distorted statements, half-truths, and blatant lies. In an official release on Thursday, Chair of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and Member (Health) in NiTi Aayog, Dr Vinod K Paul clarified the seven myths.
Japan
India
United-kingdom
Russia
New-delhi
Delhi
Bharat
Vinodk-paul
Covid-suraksha
Zydus-cadila
Pfizer
Union-government
vimarsana © 2020. All Rights Reserved.